| Active substance |
Bilastine |
| Also known as |
N/A |
| Blood pressure |
No significant effect |
| Chemical name |
4-[2-[4-[1-(2-ethoxyethyl)benzimidazol-2-yl]piperidin-1-yl]pyrimidin-4-yl]benzonitrile |
| Dosage (medical) |
20 mg once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces allergy symptoms such as sneezing, itching, watery eyes, and runny nose |
| Formula |
C28H37N5O3 |
| Half-life |
14.5 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not routinely required |
| Main action |
Histamine H1 receptor antagonist |
| Side effects |
Headache, drowsiness, dizziness, fatigue |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Strength |
20 mg |
| Substance class |
Antihistamine |
| Trade name |
Bilaxten, Ilaxten |
| Use in sports |
None |
| Water Retention |
No significant effect |
| Manufacturer |
Cipla Ltd. |
| Packing |
10 tabs/blister |
